YOUR ORTHOPEDIC AND CANCER EXERCISE SPECIALISTS Trademark

Trademark Overview


On Monday, February 26, 2024, a trademark application was filed for YOUR ORTHOPEDIC AND CANCER EXERCISE SPECIALISTS with the United States Patent and Trademark Office. The USPTO has given the YOUR ORTHOPEDIC AND CANCER EXERCISE SPECIALISTS trademark a serial number of 98421894. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Sunday, September 15, 2024. The YOUR ORTHOPEDIC AND CANCER EXERCISE SPECIALISTS trademark is filed in the Education & Entertainment Services category with the following description:

Personal fitness training services and consultancy
your orthopedic and cancer exercise specialists

General Information


Serial Number98421894
Word MarkYOUR ORTHOPEDIC AND CANCER EXERCISE SPECIALISTS
Filing DateMonday, February 26, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateSunday, September 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPersonal fitness training services and consultancy

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, February 26, 2024
Primary Code041
First Use Anywhere DateWednesday, September 7, 2022
First Use In Commerce DateSaturday, April 1, 2023

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressParrish, FL 34219

Trademark Events


Event DateEvent Description
Monday, February 26, 2024NEW APPLICATION ENTERED
Saturday, July 6, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 13, 2024ASSIGNED TO EXAMINER
Sunday, September 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 15, 2024NON-FINAL ACTION E-MAILED
Sunday, September 15, 2024NON-FINAL ACTION WRITTEN